The Hidden Truth Behind Yaz and Yasmin
As of April 2012, it’s been reported that Bayer settled 70 cases involving women who suffered venus thrombolic events (VTE) including:
- blood clots
- pulmonary embolisms
- deep vein thrombosis
FDA Warnings of Drospirenone
There are approximately 11,300 claims in state and federal courts involving the oral contraceptives Yaz and Yasmin according to Bayer. Yaz and Yasmin are in a class of drospirenone-containing oral contraceptives. The FDA warns that studies show that drospirenone is associated with a greater risk of blood clots than other forms of birth control. The lawsuits filed by our firm, and other firms around the country, allege that Yaz and Yasmin causes heart attacks, strokes, blood clots, pulmonary embolisms, deep vein thrombosis and gall bladder failure. As set forth in our Complaints, Bayer failed to adequately warn of these risks.
Federal Cases of Yaz and Yasmin
All cases filed in federal court are consolidated in multidistrict litigation (MDL) in Illinois before Judge Herndon. The first bellwether Yaz and Yasmin trials were supposed to be tried beginning September 2011. However, the MDL Judge, Judge Herndon, stayed the trial in an attempt to achieve Yaz and Yasmin settlements. The judge presiding over the Philadelphia Yaz, Yasmin litigation, Judge Sandra Mazer Moss, has also stayed the Philadelphia Yaz and Yasmin lawsuits. Along with the Yaz and Yasmin settlements, Bayer expects additional Yaz and Yasmin lawsuits to be filed.
Are You a Victim of Yaz or Yasmin?
The Levensten Law Firm is lead counsel in many Yaz, Yasmin and Ocella lawsuits that are pending in state and federal courts. We investigate and file lawsuits for patients diagnosed with a deep vein thrombosis, pulmonary embolisms, heart attacks and strokes.
If you believe you are a victim of Yaz, Yasmin or Ocella, contact our law firm for a free consultation.